IL20 and non-small cell lung carcinoma: Dysregulation of IL-20 and its receptors is frequently observed in non-small cell lung cancer (NSCLC) through epigenetic mechanisms, with the silencing of IL-20RA correlating with poorer disease-free survival outcomes in NSCLC patients (13).